Related Experiment Video
Updated: Nov 8, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy
Yaoyao Guo1, Xiaohui Feng1, Dan Wang1
1Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Insights
Diabetic cardiomyopathy (DCM) involves heart dysfunction in diabetes. Long non-coding RNAs (lncRNAs) are crucial in DCM
Area of Science:
- Cardiology
- Endocrinology
- Molecular Biology
Background:
- Diabetes mellitus is a global health concern.
- Diabetic cardiomyopathy (DCM) is a serious complication characterized by ventricular hypertrophy, fibrosis, and diastolic dysfunction.
- DCM pathogenesis involves oxidative stress, inflammation, apoptosis, autophagy, fibrosis, and microangiopathy.
Purpose of the Study:
- To review the pathological roles of long non-coding RNAs (lncRNAs) in DCM progression.
- To elucidate the molecular mechanisms of lncRNAs in DCM.
- To explore lncRNAs as potential diagnostic markers and therapeutic targets for DCM.
Main Methods:
- Literature review of recent studies on lncRNAs and DCM.
- Analysis of molecular mechanisms underlying lncRNA involvement in DCM.
- Synthesis of evidence regarding lncRNA's role in DCM pathogenesis and diagnosis.
Main Results:
- lncRNAs play critical roles in the molecular mechanisms of DCM.
- Evidence suggests lncRNAs are implicated in key pathological processes of DCM.
- lncRNAs show potential as diagnostic biomarkers for DCM.
Conclusions:
- lncRNAs are integral to DCM development and progression.
- Understanding lncRNA mechanisms offers insights into DCM pathophysiology.
- lncRNAs represent promising avenues for DCM diagnosis and treatment strategies.
Abstract:
In recent years, diabetes mellitus has become a global issue with increasing incidence rate worldwide. Diabetic cardiomyopathy (DCM), one of the important complications of diabetes, refers to patients with type 1 and type 2 diabetes who have ventricular hypertrophy, fibrosis and even diastolic dysfunction. The pathogenesis of DCM is related to oxidative stress, inflammatory response, apoptosis, autophagy, myocardial fibrosis and, diabetic microangiopathy. Long non-coding RNAs (lncRNA) is a non-coding RNA with a length longer than 200 nucleotides which lack the ability of protein coding. With the development of molecular technology, massive evidence demonstrates that lncRNA play a critical role in the molecular mechanism of DCM. Moreover, it can also be used as potential diagnostic markers for DCM. In this review, we intend to summarize the pathological roles and molecular mechanism of lncRNA in the progression of diabetic cardiomyopathy, which may provide promising diagnosis and treatment strategies for DCM.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction
Types of RNA
RNA Performs Diverse...

